scholarly journals Liquid biopsy assays using combined circulating tumour cells and circulating tumour DNA in the same patients for the diagnosis of primary lung cancer

2019 ◽  
Vol 30 ◽  
pp. v47
Author(s):  
Y. Suh ◽  
J.-S. Bae ◽  
H.S. Lee ◽  
J.-M. Moon ◽  
H.-J. Kwon ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Liquid Biopsy ◽  
Primary Lung Cancer ◽  
Tumour Cells ◽  
Circulating Tumour Cells ◽  
Circulating Tumour Dna

scholarly journals Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?

2017 ◽  
Vol 77 (12) ◽  
pp. 1291-1298 ◽  
Author(s):  
Arkadius Polasik ◽  
Marie Tzschaschel ◽  
Fabienne Schochter ◽  
Amelie de Gregorio ◽  
Thomas Friedl ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Liquid Biopsy ◽  
Venous Blood ◽  
Metastatic Breast ◽  
Tumour Cells ◽  
Circulating Microrna ◽  
Circulating Tumour Cells ◽  
Repeated Testing ◽  
Metastatic Breast Carcinoma ◽  
Circulating Tumour Dna

AbstractDissemination of tumour cells and the development of solid metastases occurs via blood vessels and lymphatics. Circulating tumour cells (CTCs) and circulating tumour DNA (ctDNA) can be detected in venous blood in patients with early and metastatic breast cancer, and their prognostic relevance has been demonstrated on numerous occasions. Repeated testing for CTCs and ctDNA, or regular so-called “liquid biopsy”, can be performed easily at any stage during the course of disease. Additional molecular analysis allows definition of tumour characteristics and heterogeneity that may be associated with treatment resistance. This in turn makes personalised, targeted treatments possible that may achieve both improved overall survival and quality of life.

scholarly journals Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer

2014 ◽  
Vol 18 (6) ◽  
pp. 775-783 ◽  
Author(s):  
Masaki Hashimoto ◽  
Fumihiro Tanaka ◽  
Kazue Yoneda ◽  
Teruhisa Takuwa ◽  
Seiji Matsumoto ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Venous Blood ◽  
Primary Lung Cancer ◽  
Tumour Cells ◽  
Circulating Tumour Cells ◽  
Surgical Manipulation

8 The utility of peripheral blood circulating tumour cells for the detection of KRAS, EGFR and BRAF mutations in primary lung cancer

Lung Cancer ◽  
2014 ◽  
Vol 83 ◽  
pp. S3-S4
Author(s):  
M.B. Freidin ◽  
D. Mair ◽  
A. Tay ◽  
D.V. Freydina ◽  
D. Chudasama ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Peripheral Blood ◽  
Primary Lung Cancer ◽  
Tumour Cells ◽  
Circulating Tumour Cells ◽  
Braf Mutations

The Prognostic Significance of Circulating Tumour Cells in Head and Neck and Non-Small Cell Lung Cancer

2018 ◽  
Author(s):  
Arutha Kulasinghe ◽  
Joanna Kapeleris ◽  
Rebecca Kimberley ◽  
Stephen R Mattarollo ◽  
Erik W Thompson ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Head And Neck ◽  
Cell Lung Cancer ◽  
Prognostic Significance ◽  
Small Cell ◽  
Tumour Cells ◽  
Circulating Tumour Cells ◽  
Small Cell Lung

Biomarkers for small cell lung cancer: Neuroendocrine, epithelial and circulating tumour cells

Lung Cancer ◽  
2012 ◽  
Vol 76 (3) ◽  
pp. 263-268 ◽  
Author(s):  
Rachel Stovold ◽  
Fiona Blackhall ◽  
Suzanne Meredith ◽  
JianMei Hou ◽  
Caroline Dive ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Tumour Cells ◽  
Circulating Tumour Cells ◽  
Small Cell Lung

Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer

Lung Cancer ◽  
2012 ◽  
Vol 76 (1) ◽  
pp. 19-25 ◽  
Author(s):  
John D. O’Flaherty ◽  
Steven Gray ◽  
Derek Richard ◽  
Dean Fennell ◽  
John J. O’Leary ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Utility ◽  
Tumour Cells ◽  
Circulating Tumour Cells
Sign in / Sign up

Export Citation Format

Share Document